Kazuya Shimoda
Miyazaki, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 188 publications
Cross-study analyses of the ropeginterferon alfa-2b effect on phlebotomy in low- and high-risk patients with polycythemia vera.
Journal: Leukemia & lymphoma
Published: July 17, 2026
Frailty and low body mass index as key determinants of sodium-glucose cotransporter 2 inhibitor-specific adverse event-related discontinuation in adults aged ≥75 years: A multicenter real-world retrospective cohort study.
Journal: Journal of diabetes investigation
Published: June 29, 2026
Case Report: Dramatic metabolic improvement with tirzepatide in a patient with acquired partial lipodystrophy following hematopoietic stem cell transplantation.
Journal: Frontiers in endocrinology
Published: April 29, 2026
Impact of Hemoglobin Improvement on Survival in Patients With Myelofibrosis and Anemia Treated With Momelotinib in the SIMPLIFY-1 and MOMENTUM Trials.
Journal: European journal of haematology
Published: April 10, 2026
The requirement of MALT1 activity for the growth of adult T cell leukemia/lymphoma.
Journal: iScience
Published: January 29, 2026
The tumor suppressor NDRG2 recruits protein phosphatase 2A to suppress STAT5 phosphorylation in adult T-cell leukemia/lymphoma.
Journal: The Journal of biological chemistry
Published: January 25, 2026
Fibrocytes drive JAK2V617F-mutated myelofibrosis: pitavastatin reverses marrow fibrosis and anemia.
Journal: Blood
Published: December 05, 2025
Cathepsin G is associated with cerebral vascular injury in myeloid leukemia: a pathologic insight into intracranial hemorrhage.
Journal: Research and practice in thrombosis and haemostasis
Published: October 06, 2025
Prospective observational study to assess the prognosis of patients with myeloproliferative neoplasms in Japan (MPN-15): results of baseline analysis.
Journal: International journal of hematology
Published: October 02, 2025
Efficacy and safety of a three-step dose escalation regimen of ropeginterferon alfa-2b in Japanese patients with polycythemia vera: a phase 3b, single-arm, multicenter study.
Journal: International journal of hematology
Published: August 25, 2025
Consensus on the use of ropeginterferon alfa-2b in Japanese patients with polycythemia vera: a modified Delphi survey.
Journal: International journal of hematology
Published: August 05, 2025
Prognostic value of lymphocyte-to-monocyte ratio in relapsed/refractory adult T-cell Leukemia/lymphoma patients receiving mogamulizumab.
Journal: Clinical immunology (Orlando, Fla.)
Published: July 01, 2025
Last Updated: 09/26/2026